Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.98B | 18.31B | 28.63B | 14.80B | 29.03B | 5.31B |
Gross Profit | 6.30B | 5.71B | 5.29B | 5.53B | 9.69B | 866.03M |
EBITDA | 3.54B | 3.14B | 3.54B | 4.90B | 8.18B | -1.00B |
Net Income | 1.56B | 1.10B | 1.82B | 3.73B | 3.51B | -1.06B |
Balance Sheet | ||||||
Total Assets | 59.26B | 62.10B | 55.23B | 49.90B | 39.39B | 25.75B |
Cash, Cash Equivalents and Short-Term Investments | 6.42B | 9.41B | 16.39B | 8.73B | 5.70B | 2.16B |
Total Debt | 30.79B | 30.33B | 29.79B | 29.64B | 23.75B | 16.19B |
Total Liabilities | 40.98B | 42.70B | 36.68B | 34.12B | 28.46B | 17.13B |
Stockholders Equity | 18.27B | 19.40B | 18.55B | 15.79B | 10.93B | 7.59B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.61B | 6.72B | -3.36B | 19.23B | -3.76B |
Operating Cash Flow | 0.00 | -3.08B | 7.03B | -3.26B | 19.28B | -3.72B |
Investing Cash Flow | 0.00 | -3.85B | -457.44M | -314.78M | -4.59B | -315.54M |
Financing Cash Flow | 0.00 | 1.92B | -1.23B | 6.59B | -11.23B | 1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥16.52B | 6.19 | ― | 5.55% | 17.92% | 15.44% | |
69 Neutral | €26.55B | 14.90 | 4.48% | 5.36% | 24.83% | -9.86% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥16.27B | 236.19 | ― | 2.62% | 11.20% | -93.41% | |
61 Neutral | ¥16.67B | 10.59 | ― | 5.63% | 36.31% | 52.62% | |
60 Neutral | ¥19.83B | 12.70 | ― | 1.93% | -30.94% | 26.14% | |
41 Neutral | ¥9.08B | ― | ― | ― | -17.04% | 46.36% |